Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Douglas E. Williams

President, CEO
Codiak Biosciences
United States of America


Douglas E. Williams, Ph.D., is Codiak’s President and CEO. He previously served as Biogen’s Executive Vice President, Research and Development from January 2011 to July 2015. Dr. Williams joined Biogen from ZymoGenetics, where he was CEO and member of the Board of Directors. Previously, he held leadership positions within the biotechnology industry, including Chief Scientific Officer and Executive Vice President of Research and Development at Seattle Genetics Inc., and Senior Vice President and Washington Site Leader at Amgen Inc. Dr. Williams also served in a series of scientific and senior leadership positions over a decade at Immunex Corp., including Executive Vice President and Chief Technology Officer, Senior Vice President of Discovery Research and Vice President of Research and Development. Prior to joining Immunex, Dr. Williams served on the faculty of the Indiana University School of Medicine and the Department of Laboratory Medicine at the Roswell Park Memorial Institute in Buffalo, New York. Dr. Williams has served on numerous boards of directors for companies in the biotechnology industry and currently is a director of Ironwood Pharmaceuticals, Regulus Therapeutics and Ovid Therapeutics. 

Research Interest

Novel, targeted medicines for diseases, unique properties of exosomes, nucleic acids, proteins, lipids and small molecules, natural tropism of exosomes for delivery of payloads to specific cell and tissue types, delivering macromolecules across biological membranes 

Global Experts from United States of America

Global Experts in Subject

Share This Profile
Recommended Conferences